However, based on the influence of mTOR on gut microbiota, genetic polymorphisms, and epigenetics on the development of NAFLD, this paper has not fully elaborated on this area which still needs researchers to continue their efforts. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.